Phenotypic characterization of T cells in bronchoalveolar lavage fluid (BALF) and peripheral blood of patients with diffuse panbronchiolitis; the importance of cytotoxic T cells

Clinical and Experimental Immunology

Volumn 107, Issue 2, 1997, Pages 410-416

  Kawakami, K ^a   Kadota, J ^a,b   Iida, K ^a   Fujii, T ^a   Shirai, R ^a   Matsubara, Y ^a   Kohno, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Second Dept of Internal Medicine   (Japan)

Author keywords

bronchoalveolar lavage fluid; cytotoxic T cells; diffuse panbronchiolitis; macrolide antibiotics; memory T cells

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CLARITHROMYCIN; ERYTHROMYCIN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MACROLIDE; ROXITHROMYCIN; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; BACTERIAL INFECTION; BRONCHIOLITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DIFFUSE PANBRONCHIOLITIS; FEMALE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LUNG LAVAGE; MALE; MEMORY CELL; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0031032756     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.259-ce1139.x     Document Type: Article

References (30)

1. Homma H, Yamanaka A, Tanimoo S et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983; 83:63-69.
2. Kudoh S, Uetake T, Hagiwara K et al. Clinical effect of low-dose longterm erythromycin chemotherapy on diffuse panbronchiolitis. Jpn J Thorac Dis 1987; 25:632-42.
3. Kadota J, Sakito O, Kohno S et al. Roxithromycin treatment in patients with chronic lower respiratory tract diseases - its clinical efficacy and effect on cytokine. J Jpn Assoc Inf Infect Dis 1994; 68:27-33.
4. Mikasa K, Sawaki M, Kita E et al. Long-term chemotherapy using erythromycin (EM) for chronic lower airway infection: effectiveness of clarithromycin in EM ineffective cases - the fourth report. J Jpn Assoc Infect Dis 1992; 66:1097-104.
5. Ichikawa Y, Ninomiya H, Koga H et al. Erythromycin reduces neutrophils and neutrophil-derived elastolytic-like activity in the lower respiratory tract of bronchiolitis patients. Am Rev Respir Dis 1992; 146:196-203.
6. Kadota J, Sakito O, Kohno S et al. A mechanism of erythromycin treatment in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 147:153-9.
7. Mukae H, Hirota M, Kohno S et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993; 148:744-51.
8. Sato A, Chida K, Iwata M et al. Study of bronchus-associated lymphoid tissue in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1992; 146:473-8.
9. Kindt GC, Weiland JE, Davis WB et al. Bronchiolitis in adults: a reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am Rev Respir Dis 1989; 140:483-92.
10. Thompson AB, Daughton D. Robbins RA et al. Intraluminal airway inflammation in chronic bronchitis: characterization and correlation with clinical parameters. Am Rev Respir Dis 1989; 140:1527-37.
11. Silvia LE Jr, Jones JAH, Cole PJ et al. The immunological component of the cellular inflammatory infiltrate in bronchiectasis. Thorax 1989; 44:668-73.
12. Fournier M, Lebargy F, Ladurie FLR et al. Intraepithelial T-lymphocyte subsets in the airways of normal subjects and of patients with chronic bronchitis. Am Rev Respir Dis 1989; 140:737-42.
13. Saetta M, Stefano AD, Maestrelli P et al. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993; 147:301-6.
14. Mukae H, Kadota J, Kohno S et al. Increase in activated CD8 cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Crit Care Respir Med 1995; 152:613-8.
15. Bienenstock J. Bronchus-associated lymphoid tissue. In: Bienenstock J, ed. Immunology of the lung and upper respiratory tract. New York: McGraw Hill, 1984:96-118.
16. Bienenstock J, Befus D. Gut- and bronchus-associated lymphoid tissue. Am J Anat 1984; 170:437-45.
17. Morimoto C, Letvin NL, Boyd AW et al. The isolation and characterization of the human helper inducer T cell subset. J Immunol 1985; 134:3762-9.
18. Morimoto C, Letvin NL, Distaso JA et al. The isolation and characterization of the human suppressor inducer T cell subset. J Immunol 1985; 134:1508-15.
19. + helper/inducer T lymphocytes Detined by anti-CD45R antibodies derive sequentially from a differentiation pathway that is regulated by activation-dependent post-thymic differentiation. J Immunol 1988; 141:1464-70.
20. Sanders ME, Makgoba MW, Shaw S. Human naive and memory T cells: reinterpretation of helper-inducer and suppressor-inducer subsets, Immunol Today 1988; 9:195-9.
21. Pilewski JM, Albelda SM. Adhesion molecules in the lung. Am Rev Respir Dis 1993; 148 (Suppl.):S31-S37.
22. Arnaout MA. Structure and function of the leukocyte adhesion molecules CD11/CD18. Blood 1990; 75:1037-50.
23. Hemler M, Elices M, Parker C et al. Structure of the integrin VLA-4 and its cell-cell and cell-matrix adhesion functions. Immunol Rev 1990; 114:45-65.
24. Dustin ML, Springer TA. T-cell receptor cross-linking transiently stimulates adhesiveness through LFA-1. Nature 1989; 341:619-24.
25. Shimizu Y, Seventer GAV, Horgan KJ et al. Regulated expression and binding of three VLA (β1) integrin receptors on T cells. Nature 1990; 345:250-3.
26. Sanders ME, Makgoba MW, Sharrow SO et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CD29w, and Pgp-1) and have enhanced IFN-γ production. J Immunol 1988; 140:1401-7.
27. Nagai H, Shishido H, Yoneda R et al. Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis. Respiration 1991; 58:145-9.
28. Suwabe A, Yakuwa N, Nakamura H et al. Effects on blood leukocyte functions of long term therapy with low doses of erythromycin in diffuse panbronchiolitis. Jpn J Thorac Dis 1988; 26:1284-90.
29. Sugiyama Y, Sugawa Y, Takeuchi K et al. Analysis of peripheral lymphocyte subsets and changes due to erythromycin therapy in patients with diffuse panbronchiolitis. Jpn J Thorac Dis 1990; 28:1574-80.
30. Keicho N, Kudoh S, Yotsumoto H et al. Antilymphocytic activity of erythromycin distinct from that of FK506 or cyclosporin A. J Antibiot (Tokyo) 1993; 46:1406-13.